Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19 is a research paper published in Immunology and Cell Biology (2021). On theSindex it has a DataRank of 0. It has been cited 100 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NHGRI NIH HHS
Grant: UM1 HG006504
National Human Genome Research Institute
Grant: U24HG008956
Agence Nationale de la Recherche
Grant: ANR-10-LABX-62-IBEID
NIH HHS
Grant: R01AI088364
NCATS NIH HHS
Grant: UL1 TR001863
Agence Nationale de la Recherche
Grant: ANR-10-IAHU-01
National Center for Advancing Translational Sciences
Grant: UL1 TR001866
Agence Nationale de la Recherche
Grant: ANR‐10‐IAHU‐01
Agence Nationale de la Recherche
Grant: ANR‐10‐LABX‐62‐IBEID
Fondation pour la Recherche Médicale
Grant: EQU201903007798
Intramural NIH HHS
Grant: ZIA AI001318
National Institutes of Health
Grant: 5U24HG008956-02
NHGRI Genome Sequencing Program Coordinating Center
National Institutes of Health
Grant: 5UL1TR001866-07
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success
National Institutes of Health
Grant: 5UM1HG006504-07
Yale Center for Mendelian Genomics
National Institutes of Health
Grant: 5R01AI088364-15
Inborn errors of immunity in children with herpes simplex encephalitis
Division of Intramural Research, National Institute of Allergy and Infectious Diseases
Regione Lombardia
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study
Additional file 1 of Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study